Trials / Completed
CompletedNCT01771653
Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Southern Illinois University · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to compare two approved treatment regimen(s) containing boceprevir and telaprevir, as part of standard of care for the treatment of hepatitis C.
Detailed description
The objective of the study is to compare the effect of adding 2 oral hepatitis C virus (HCV) protease inhibitors, telaprevir versus boceprevir, as part of current standard treatment regimen with (pegylated-interferon-alpha + ribavirin) for HCV Genotype-1 infection. Data will be obtained from medical records of consenting patients.
Conditions
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2013-01-18
- Last updated
- 2016-01-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01771653. Inclusion in this directory is not an endorsement.